Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-07

Clinical Trial Update: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing potential adrenal suppression following treatment with DSXS in patients with plaque psoriasis; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DSXS

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-07